[Clinical analysis of the correlation between the expression of soluble B cell maturation antigen and the efficacy of chimeric antigen receptor T cell targeting B cell maturation antigen in patients with multiple myeloma].

S Q Gao, J Mu, X Li, J Wang, R Cui, J Y Li, T Sui, Q Deng

Abstract readEnglish Abstract

In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Correlation between the expression of soluble BCMA and short-term/long-term curative effect and survival outcomes of anti-BCMA CAR-T cell therapy in relapsed/refractory multiple myeloma.Cell transplantation
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S Q GaoDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

J MuDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

X LiDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

J WangDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

R CuiDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

J Y LiDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

T SuiDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

Q DengDepartment of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.

Funding

Chinese Society of Clinical Oncology Beijing Xisike Clinical Oncology Research Foundation Y-SY2021QN-0184, Y-Young2022-0209, Y-NCJH202201-0027Tianjin Health Research Project TJWJ2022XK021, TJWJ2023ZD003

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B-Cell Maturation AntigenImmunotherapy, AdoptiveMultiple MyelomaReceptors, Chimeric AntigenBone MarrowFemaleHumansMaleMiddle AgedT-LymphocytesB-Cell Maturation AntigenReceptors, Chimeric AntigenChimeric antigen receptor T cellMultiple myelomaSoluble B cell maturation antigen

Identifiers

PMID38951066

DOI10.3760/cma.j.issn.0253-2727.2023.01.001

PMCPMC11168002

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.